S-antigen visual arrestin (SAG)

S-antigen visual arrestin (SAG) is a soluble regulatory protein predominantly expressed in the retina and pineal gland, belonging to the arrestin/beta-arrestin family[1][5]. It plays a critical role in the desensitization of the phototransduction pathway by binding to photoactivated, phosphorylated rhodopsin (RHO) and terminating its signaling by preventing further coupling to the G-protein transducin[1][2][5]. This process is essential for shutting down light-induced signaling and maintaining visual sensitivity. Mutations in the SAG gene are associated with inherited night blindness (Oguchi disease) and some forms of retinitis pigmentosa[1][3]. SAG is also highly antigenic, and immune responses against it are implicated in autoimmune conditions such as uveitis[1][2]. There are no approved therapeutics specifically acting on this protein, but it is a key molecular node in vision and immune-related ocular pathology.

Other names

S-arrestinS-antigen48 kDa proteinretinal S-antigenvisual arrestinretina-specific arrestin

no approved drug mechanisms acting on this exact target; hypothetically, agents could modulate phototransduction or immune tolerance